Table 2.
Trial | N | Stage concordance (%) | LS |
ES |
||
---|---|---|---|---|---|---|
N | Up-staged (LS→ES) (%) | N | Down-staged (ES→LS) (%) | |||
Prospective | ||||||
Chin[19] | 18 | 83 | 9 | 22 | 9 | 11 |
Bradley[21] | 24 | 88 | 24 | 8 | 0 | – |
Brink[22] | 120 | 88 | 51 | 20 | 69 | 4 |
Kut[24] | 18 | 100 | 6 | 0 | 12 | 0 |
Fischer[25] | 29 | 83 | 9 | 33 | 20 | 5 |
Subtotal | 209 | 89 | 99 | 17 | 110 | 5 |
Retrospective | ||||||
Haubner[16] | 7 | 100 | 6 | 0 | 1 | 0 |
Schumacher[17] | 26 | 73 | 13 | 54 | 13 | 0 |
Shen[18] | 25 | 92 | 10 | 10 | 15 | 7 |
Kamel[20] | 24 | 83 | 17 | 18 | 7 | 14 |
Blum[23] | 15 | 67 | 15 | 33 | 0 | – |
Vinjamuri[26] | 51 | 82 | 18 | 6 | 33 | 18 |
Azad[27] | 46 | 74 | 26 | 15 | 20 | 40 |
Subtotal | 194 | 80 | 105 | 20 | 89 | 18 |
Total | 403 | 84 | 204 | 19 | 199 | 11 |